Dianthus Therapeutics Q1 2026 Earnings Narrower Loss Surprises as PreRevenue Biotech Advances Pipeline ASUR Q1 2026 Earnings EPS Surpasses Estimates by 183 Recurring Revenue Growth Drives Profitability Customers Bancorp Inc CUBI Q1 2026 Earnings EPS Beats Estimates Despite Modest Stock Decline Azitra Q1 2026 Earnings Significant EPS Miss Amid Development Stage Operations ACB Q1 2026 Earnings EPS Miss Tempers Optimism After Return to Profitability CUK Q1 2026 Earnings EPS Meets Estimate Narrowly Stock Lifts 66